Home / Treatments / Electron Beam Computed Tomography

Electron Beam Computed Tomography denials: what the review data shows

Independent reviewers have decided 15 published cases where an insurer denied Electron Beam Computed Tomography — and they overturned the insurer 6.7% of the time. A denial for Electron Beam Computed Tomography is a starting position, not a final answer.

Published decisions
15
2001–2026
Overturned
6.7%
1 denials reversed

Conditions behind electron beam computed tomography denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Coronary Artery Disease7
0%
Hyperlipidemia3
33.3%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
12
8.3%
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
3
0%
Typical time to a decision
23 days
Most land between 20 and 29 days
Handled as urgent
6.7%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for electron beam computed tomography (EBCT). Coronary artery calcification has been shown to add incremental benefit to traditional risk prediction models to assess for risk of coronary artery disease. On review of the available documentation, this patient has hyperlipidemia with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of about 7.5%. Based on the American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, the patient should be treated with a moderate to high dose statin. However, the provider noted that the patient has been unable to tolerate treatment with statins. The patient’s cholesterol is rising despite eating a vegetarian diet and attending Weight Watchers.
Experimental/Investigational · 2023 · IMR EI23-38644

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Physician 1: The patient is a 50-year-old female with a history of hyperlipidemia and low levels of HDL treated with gemfibrozil and Pravachol. She had a baseline EBCT in 2003 and a second imaging study in June 2005. The Health Plan denied the patient’s request for reimbursement of the follow-up study based upon their determination that EBCT is considered experimental/ investigational for evaluation of coronary artery disease. In adults at low risk for coronary heart disease (CHD) events, the United States Preventive Services Task Force (USPSTF) now recommends against routine screening for either the presence of severe coronary artery stenosis (CAS) or the prediction of CHD events with resting electrocardiography (ECG), exercise treadmill test (ETT), or electron-beam computed tomography (EBCT) scanning for coronary calcium.
Experimental/Investigational · 2005 · IMR EI05-5058
Physician 1: The enrollee is a 60-year-old woman who may have chest pain syndrome. Her cholesterol is elevated to 221, but with a favorable ratio of HDL to LDL (HDL= 83, LDL= 110). The patient’s only reported risk factors are that is 60-year-old and apparently has family history of coronary artery disease. Documentation of other risk factors (smoking, diabetes and hypertension) are not provided.EBCT is not recommended as a general population screening test for coronary artery disease by the ACC or by the USPSTF guidelines. The standard of care would be to work up her chest pain with a stress test (treadmill) or a perfusion stress test (if EKG is abnormal). In symptomatic women with an intermediate likelihood of coronary artery disease, either an exercise treadmill test or an exercise echocardiogram is appropriate for initial screening.
Experimental/Investigational · 2005 · IMR EI05-4365

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Electron Beam Computed Tomographywhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Electron Beam Computed Tomography? 6.7% got it reversed.

Explain my denial — freeStart my appeal · $39